Changes in Beneficial Ownership · 4
Colgate-Palmolive Company
CLNYSEEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
doc4.xml
Filing details
- Report period
- 2026-08-04
- Issuer
- COLGATE PALMOLIVE CO
- Issuer CIK
- 0000021665
- Trading symbol
- CL
Reporting owner 1
- Name
- Wallace Noel R.
- Reporting owner CIK
- 0001464265
- Relationship
- Director · Officer
- Officer title
- Chairman, President & CEO
- Address
- C/O COLGATE-PALMOLIVE COMPANY, 300 PARK AVENUE, NEW YORK, NY, 10022
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-08-04 | M · Form 4[F1] | 161,021.0000 | A | 72.2900 | 523,252.0000 | D |
| Common Stock | 2026-08-04 | S · Form 4[F2] | 161,021.0000 | D | 91.9179[F3] | 362,231.0000 | D |
| Common Stock | 2026-08-05 | M · Form 4[F1] | 161,021.0000 | A | 72.2900 | 523,252.0000 | D |
| Common Stock | 2026-08-05 | S · Form 4[F2] | 161,021.0000 | D | 92.5215[F4] | 362,231.0000 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- A
- Acquired
- D
- Direct
- S · Form 4
- Sale on the market or privately
Non-derivative holdings
| Security | Amount owned | Ownership | Nature of ownership |
|---|---|---|---|
| Common Stock | 54,868.0000 | I | By Issuer's 401(k) Plan Trustee |
| Common Stock | 52,000.0000 | I | By Spouse Trust |
| Common Stock | 335.0000 | I | By Trust |
Table key
- I
- Indirect
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | 72.2900 | 2026-08-04 | M · Form 4[F1] | 161,021.0000 | D | 0.0000 | [F5] | 2027-09-12 | Common Stock | 161,021.0000 | 161,021.0000 | D |
| Stock Option (Right to Buy) | 72.2900 | 2026-08-05 | M · Form 4[F1] | 161,021.0000 | D | 0.0000 | [F5] | 2027-09-12 | Common Stock | 161,021.0000 | 0.0000 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- D
- Direct
Footnotes
- F2
- Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.↩ 1↩ 2
- F3
- Weighted average price, as these shares were sold in multiple transactions at prices ranging from $91.50 to $92.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.↩ 1
- F4
- Weighted average price, as these shares were sold in multiple transactions at prices ranging from $92.00 to $92.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.↩ 1
Signature 1
- Signed
- /s/ Kristine Hutchinson, Attorney-in-Fact
- Date
- 2026-08-06